Viewing Study NCT03641560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-03-05 @ 3:57 AM
Study NCT ID: NCT03641560
Status: COMPLETED
Last Update Posted: 2025-04-08
First Post: 2018-08-20
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration Resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) View
None Enzalutamide View
None Xtandi View
None MDV3100 View